These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32124974)

  • 1. Treatment of chronic alopecia areata with tildrakizumab: an open-label pilot study.
    Kerkemeyer KLS; Sinclair R
    Int J Dermatol; 2020 May; 59(5):e136-e137. PubMed ID: 32124974
    [No Abstract]   [Full Text] [Related]  

  • 2. Dupilumab Improved Alopecia Areata in a Patient with Atopic Dermatitis: A Case Report.
    Uchida H; Kamata M; Watanabe A; Agematsu A; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    Acta Derm Venereol; 2019 Jun; 99(7):675-676. PubMed ID: 30938821
    [No Abstract]   [Full Text] [Related]  

  • 3. Benefit of different concentrations of intralesional triamcinolone acetonide in alopecia areata: An intrasubject pilot study.
    Chu TW; AlJasser M; Alharbi A; Abahussein O; McElwee K; Shapiro J
    J Am Acad Dermatol; 2015 Aug; 73(2):338-40. PubMed ID: 26183987
    [No Abstract]   [Full Text] [Related]  

  • 4. An open-label study evaluating the efficacy of abatacept in alopecia areata.
    Mackay-Wiggan J; Sallee BN; Wang EHC; Sansaricq F; Nguyen N; Kim C; Chen JC; Christiano AM; Clynes R
    J Am Acad Dermatol; 2021 Mar; 84(3):841-844. PubMed ID: 33045294
    [No Abstract]   [Full Text] [Related]  

  • 5. Dupilumab therapy for alopecia areata in pediatric patients with concomitant atopic dermatitis.
    McKenzie PL; Castelo-Soccio L
    J Am Acad Dermatol; 2021 Jun; 84(6):1691-1694. PubMed ID: 33484763
    [No Abstract]   [Full Text] [Related]  

  • 6. Dupilumab and alopecia: A Janus effect.
    Patruno C; Napolitano M; Ferrillo M; Fabbrocini G
    Dermatol Ther; 2019 Sep; 32(5):e13023. PubMed ID: 31306557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of adalimumab for the treatment of severe alopecia areata: case series of three patients.
    Bolduc C; Bissonnette R
    J Cutan Med Surg; 2012; 16(4):257-60. PubMed ID: 22784518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of persistent alopecia areata with sulfasalazine.
    Rashidi T; Mahd AA
    Int J Dermatol; 2008 Aug; 47(8):850-2. PubMed ID: 18717871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ruxolitinib for the treatment of severe alopecia areata.
    Liu LY; King BA
    J Am Acad Dermatol; 2019 Feb; 80(2):566-568. PubMed ID: 30195572
    [No Abstract]   [Full Text] [Related]  

  • 10. Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study.
    Strober BE; Siu K; Alexis AF; Kim G; Washenik K; Sinha A; Shupack JL
    J Am Acad Dermatol; 2005 Jun; 52(6):1082-4. PubMed ID: 15928633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of efficacy of apremilast in 9 patients with severe alopecia areata.
    Liu LY; King BA
    J Am Acad Dermatol; 2017 Oct; 77(4):773-774. PubMed ID: 28917463
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporin A and alopecia areata.
    Moreno JC; Ocaña MS; Vélez A
    J Eur Acad Dermatol Venereol; 2002 Jul; 16(4):417-8. PubMed ID: 12224710
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of secukinumab treatment in adults with extensive alopecia areata.
    Guttman-Yassky E; Nia JK; Hashim PW; Mansouri Y; Alia E; Taliercio M; Desai PN; Lebwohl MG
    Arch Dermatol Res; 2018 Oct; 310(8):607-614. PubMed ID: 30121698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diphencyprone for the treatment of alopecia areata: more data and new aspects.
    Happle R
    Arch Dermatol; 2002 Jan; 138(1):112-3. PubMed ID: 11790175
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of topical dithranol (Dithrocream
    Daunton A; Harries M
    Br J Dermatol; 2019 May; 180(5):1246-1247. PubMed ID: 30536990
    [No Abstract]   [Full Text] [Related]  

  • 16. Dual efficacy of dupilumab in a patient with concomitant atopic dermatitis and alopecia areata.
    Darrigade AS; Legrand A; Andreu N; Jacquemin C; Boniface K; Taïeb A; Seneschal J
    Br J Dermatol; 2018 Aug; 179(2):534-536. PubMed ID: 29710431
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations.
    Le Duff F; Bouaziz JD; Fontas E; Ticchioni M; Viguier M; Dereure O; Reygagne P; Montaudié H; Lacour JP; Monestier S; Richard MA; Passeron T
    J Invest Dermatol; 2021 Apr; 141(4):933-936.e6. PubMed ID: 32941917
    [No Abstract]   [Full Text] [Related]  

  • 18. Alefacept for severe alopecia areata: a randomized, double-blind, placebo-controlled study.
    Strober BE; Menon K; McMichael A; Hordinsky M; Krueger G; Panko J; Siu K; Lustgarten JL; Ross EK; Shapiro J
    Arch Dermatol; 2009 Nov; 145(11):1262-6. PubMed ID: 19917955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alopecia areata predictive score: A new trichoscopy-based tool to predict treatment outcome in patients with patchy alopecia areata.
    Waśkiel-Burnat A; Rakowska A; Sikora M; Olszewska M; Rudnicka L
    J Cosmet Dermatol; 2020 Mar; 19(3):746-751. PubMed ID: 31301100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of alopecia areata with prednisone in a once-monthly oral pulse].
    Ait Ourhroui M; Hassam B; Khoudri I
    Ann Dermatol Venereol; 2010; 137(8-9):514-8. PubMed ID: 20804894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.